Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Operating Income (2023 - 2024)

Historic Operating Income for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q4 2024 value amounting to -$18.3 million.

  • Artiva Biotherapeutics' Operating Income fell 5260.65% to -$18.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$67.3 million, marking a year-over-year change of. This contributed to the annual value of -$67.3 million for FY2024, which is 11936.68% down from last year.
  • Artiva Biotherapeutics' Operating Income amounted to -$18.3 million in Q4 2024, which was down 5260.65% from -$18.3 million recorded in Q3 2024.
  • Over the past 5 years, Artiva Biotherapeutics' Operating Income peaked at $10.8 million during Q3 2023, and registered a low of -$18.3 million during Q3 2024.